BiotechTube

Hetrombopag Olamine

Phase 1UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Purpura, Thrombocytopenic, Idiopathic

Conditions

Purpura, Thrombocytopenic, Idiopathic

Trial Timeline

Apr 1, 2014 → —

NCT ID
NCT02403440

About Hetrombopag Olamine

Hetrombopag Olamine is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Purpura, Thrombocytopenic, Idiopathic. The current trial status is unknown. This product is registered under clinical trial identifier NCT02403440. Target conditions include Purpura, Thrombocytopenic, Idiopathic.

What happened to similar drugs?

1 of 20 similar drugs in Purpura, Thrombocytopenic, Idiopathic were approved

Approved (1) Terminated (1) Active (18)
❌Eltrombopag + Avatrombopag + Standard of careEisaiPhase 3
🔄Hetrombopag Olamine + matching placeboJiangsu Hengrui MedicinePhase 3
🔄EltrombopagNovartisPhase 3
🔄eltrombopag + placeboNovartisPhase 3
🔄Eltrombopag + IVIG infusionNovartisPhase 3
🔄eltrombopag olamine (SB-497115-GR)NovartisPhase 3
🔄Eltrombopag Tablets + Eltrombopag PfOSNovartisPhase 3

Hype Score Breakdown

Clinical
6
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (7)

NCT IDPhaseStatus
NCT05944211Phase 2Recruiting
NCT03977805Phase 1Completed
NCT03603132Phase 1Completed
NCT03557099Phase 1/2Completed
NCT02614846Phase 1UNKNOWN
NCT02403440Phase 1UNKNOWN
NCT02409394Phase 1Completed

Competing Products

20 competing products in Purpura, Thrombocytopenic, Idiopathic

See all competitors
ProductCompanyStageHype Score
E5501EisaiPhase 1
29
E5501 + Drug: E5501EisaiPhase 1
29
E5501 40 mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food + E5501 40mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with foodEisaiPhase 1
29
Eltrombopag + Avatrombopag + Standard of careEisaiPhase 3
32
Placebo + Avatrombopag tabletsEisaiPhase 2
35
Blinded (placebo) + Open Label (Avatrombopag tablets) + Blinded (Avatrombopoag tablets)EisaiPhase 2
35
10-mg dose of E5501 2G tablet + 10-mg dose of E5501 cyclodextrin oral solution + 10-mg dose of E5501-P21% powder + 10-mg dose of E5501 lipid-based oralEisaiPhase 1
29
AMG 531Kyowa KirinPhase 2/3
38
Romiplostim (AMG-531)Kyowa KirinPhase 2
35
Hetrombopag Olamine + matching placeboJiangsu Hengrui MedicinePhase 3
40
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 1
25
MK-8723 + Matching PlaceboMerckPhase 1
29
EltrombopagNovartisPhase 2
35
eltrombopagNovartisPhase 2
35
EltrombopagNovartisPre-clinical
26
EltrombopagNovartisPhase 3
36
eltrombopag + placeboNovartisPhase 3
40
Eltrombopag + IVIG infusionNovartisPhase 3
40
eltrombopag olamine (SB-497115-GR)NovartisPhase 3
40
Eltrombopag Tablets + Eltrombopag PfOSNovartisPhase 3
40